We found that three SNPs at 18q21.1 (rs77544449, rs60385309 and rs72917785), all in strong LD with rs7229639, affect enhancer activity, and potentially the expression of LIPG, which encodes endothelial lipase (EL), hence contributing to CRC risk. The gene discussed is LIPG; the disease is colorectal carcinoma.